ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,419,551, issued on Sept. 23, was assigned to Senseonics Inc. (Germantown, Md.).
"Mediation of in vivo analyte signal degradation" was invented by Joon Chatterjee (Germantown, Md.), Sanat Mohanty (Germantown, Md.) and Philip Huffstetler (Germantown, Md.).
According to the abstract* released by the U.S. Patent & Trademark Office: "A sensor (e.g., an optical sensor) that may be implanted within a living animal (e.g., a human) and may be used to measure an analyte (e.g., glucose or oxygen) in a medium (e.g., interstitial fluid, blood, or intraperitoneal fluid) within the animal. The sensor may include a sensor housing, an analyte indicator covering at least a portion of the sensor housi...